FDA Drug Recalls

Recalls / Class II

Class IID-1614-2015

Product

Morphine 70 mg/ml + Bupivacaine 40 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN

Affected lot / code info
All lots distributed between November 2014 and May 2015 03222015@80, 5/31/2015; 03202015@77, 6/18/2015

Why it was recalled

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Recalling firm

Firm
The Compounding Pharmacy of America
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
6216 Highland Place Way Ste 101-A, Knoxville, Tennessee 37919-4068

Distribution

Quantity
44 ml total volume
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-06-02
FDA classified
2015-09-15
Posted by FDA
2015-09-23
Terminated
2016-02-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1614-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls